Introduction
Juvenile recurrent parotitis (JRP) in children is a rare clinical condition which is characterized with recurrent episodes of non-obstructive and non-suppurative parotid gland inflammation. The etiology of JRP is not fully understood. It presents with mostly unilateral but sometimes bilateral painful parotid swelling, recurring at least twice, usually accompanied by fever and malaise. The orifice of the parotid gland duct is usually dilated and surrounded by white-yellow plaques. Episodes usually manifest between 3-6 years with a male preponderance, last between 1 day and 2 weeks, occur every 3-4 months, and tend to resolve spontaneously during puberty in most patients (1) (2) (3) .
The diagnosis of JRP is mainly based on history and physical examination findings in children with ≥ 2 attacks of acute parotitis (4) . It may be distinguished from suppurative parotitis by the absence of pus. Preliminary diagnosis is frequently confirmed by the demonstration of "sialectasia" (multiple hypoechoic regions and punctate calcifications) by ultrasonography (US) (4) (5) (6) (7) (8) .
The treatment of JRP generally consists of relief of acute symptoms and prevention of glandular parenchymal damage. First step measures are maintenance of good oral hygiene, adequate hydration, warm massage to the parotid gland, use of sialogogues and analgesics (7) . The administration of antibiotics during attacks is controversial. Although many authors suggest their use, some do not agree (9) (10) (11) . More recently, increasing evidence indicate success of sialendoscopy in the diagnosis and treatment of JRP (12, 13) .
This study aimed to draw attention to JRP, a rare clinical condition, which represents as a diagnostic challenge for many physicians. For this purpose, we retrospectively reviewed the medical charts of children diagnosed with JRP. Under the light of our findings and review of the literature, we aimed to emphasize the diagnosis, management and outcome of this condition.
Materials and Methods

Patients and Study Design
This retrospective cohort study was conducted in Ankara University Children's Hospital. We have reviewed the medical charts of eleven children who were diagnosed with JRP between November 2014-June 2018. Diagnosis of juvenile recurrent parotitis was made clinically in children with ≥ 2 attacks of acute non-suppurative parotitis, and further confirmed with US. Exclusion criteria were outlined as incomplete data and detection of a mass lesion (eg. stone, tumor) located in the parotid gland ducts.
A comprehensive history including the age of initiation, duration, laterality and frequency of the episodes were recorded for each patient. Familial occurrence, signs suggestive of autoimmune diseases (eg. skin rash, dry mouth, dry eyes or joint swelling), as well as immune deficiencies were evaluated. Physical examination findings with particular attention on parotitis were reviewed.
The results of acute phase reactants [(erythrocyte sedimentation rate, serum C-reactive protein (CRP)] and serum amylase levels, immune function tests (absolute lymphocyte and neutrophil counts, immunoglobulin G, A, M levels), serum rheumatoid factor, autoantibody profile [antinuclear antibodies (ANA), anti-double stranded DNA (anti-dsDNA) antibodies, anti-RNP antibodies, anticardiolipin, anti-smooth muscle antibody (anti-SMA), antiphospholipid antibodies and anti-Ro (SS-A), anti-La (SS-B) antibodies], serum complement levels (C3, C4), and infectious markers (anti-mumps Ig M, anti HAV IgM, HbsAg, anti HCV, anti HIV, anti CMV IgM, anti EBV IgM, anti-toxoplasma IgM) were evaluated. Ultrasound findings and results of other imaging studies if available (eg. MRI, CT), treatment modalities and clinical outcomes were noted for each patient. Phone contacts with families were carried out to gather information about long term outcome in case of inadequate data.
Ethical approval:
The study protocol was approved by Ankara University Clinical Research Ethical Commitee (Study approval number: 11-732-18, June 2018).
Statistical Analysis
Statistical analysis of this study was performed using the SPSS statistical package (v.21.0). Comparison analysis were not made as it was designed as a descriptive study. Counts and percentages for categorical variables; median values and ranges for continuous variables were reported.
Results
A total of 11 children (6 female, 5 male) with a median age of 5 (2.5-13.5) years were identified during the study period. The median age of presentation of episodes was 3 (2-7) years. Three patients were diagnosed following their second attack while number of previous episodes before diagnosis was at most 25. The time period between the initiation of symptoms and time of diagnosis varied between 2 months and 6.5 years.
Ten of these patients received mumps vaccine in accordance with our universal vaccination schedule. All patients signified a prior diagnosis of mumps concerning their first episode of parotitis. Episodes were treated conservatively (n= 9) or with antibiotics (n= 2) prior to diagnosis of JRP. None of the patients signified a family history of recurrent parotitis. One patient's father was learned to have a diagnosis of ankylosing spondylitis. Signs related with autoimmune diseases (eg. skin rash, arthritis, e3 Çullas İlarslan et al. dry eyes or dry mouth) were not mentioned by any family. Two patients denoted frequent use of antibiotics for upper respiratory tract infections.
All children presented with painful parotid swelling. Seven children had fever during episodes. Physical examination revealed firm, smooth and tender parotid swelling. Parotid swelling was unilateral in 7 patients and bilateral in 4 patients. Local erythema of the overlying skin was observed in five patients. There was no pus when pressure was applied to the Stenson's duct opening. The episodes lasted between 3-10 days. The de-mographic and clinical characteristics of children diagnosed with JRP are shown in Table 1 . Table 2 . Leukocytosis and increased acute phase reactant levels were observed in some patients. All patients had high serum amylase level (> 100 U/L). Acute infectious markers including anti-mumps Ig M were negative in all children.
Laboratory investigations are listed in
All patients were evaluated for accompanying illnesses, such as autoimmune diseases and immunodeficiencies. Auto- immune marker evaluation showed positive ANA titers in four patients. Three of these patients were consulted to pediatric rheumatology. Even though a specific diagnosis was not made because of the absence of additional positive findings suggestive of a rheumatologic disease, follow-up was recommended.
Other autoimmune markers including antibodies for Sjogren's syndrome (SS-A, SS-B) were negative in all patients. Immune function tests delineated low Ig A in two patients and low Ig M in one patient ( Table 3 ). As exact discrimination between transient hypogammaglobulinemia of infancy and selective hypogamaglobulinemia (Ig A or Ig M) could not be accomplished, definitive diagnosis were assumed to be made in the follow-up. Pediatric immunology consultation resulted with no additional immunologic defect.
Ultrasonographic evaluation revealed unilateral or bilateral enlarged parotid glands with multiple hypoechoic areas within the parenchyma (Figure 1 ). Ductal stones, abscesses or mass lesions were not detected in any patient. Incidentally, patient 2 had cranial MRI 3 months later because of epilepsy, which signified heterogeneous parenchyma with sialoectatic foci in both parotid glands.
All children were treated conservatively with analgesics and empirical antibiotics (amoxicillin-clavulanate [50 mg/kg/ day, 7 days]). Follow-up period of eleven patients varied from 5 to 44 months. Number of repeated attacks following diagnosis varied from 1 to 12 (Table 4 ).
Discussion
Recurrent parotitis in children is defined as intermittent inflammation of one or both parotid glands. Although the exact incidence is not clear, it is known as a rare clinical condition, since most reports consist of small case series (4, 9, 14) . Even so, JRP was referred as the second most frequent disease of the parotid gland in children after mumps before the implementation of mumps vaccine in many countries (15, 16) . Herein, we have presented our series to raise awareness to this clinical entity.
Although the pathophysiology of JRP is not fully elucidated, it is believed to be multifactorial. One possible explanation is reduced flow or modified content of saliva which induces stasis, recurrent retrograde inflammation and thus damage to the ductules, with further development of sialectasis over time (5, 9) . Another theory suggests that baseline structural abnormalities of the gland ductules represent as the main trigger for recurrent inflammation (9) . Furthermore, genetic factors, dental malocclusion, viral infections, autoimmune diseases (eg. Sjogren's), allergy, sarcoidosis and immune defects such as selective Ig A deficiency have all been reported as accompanying diseases (4, 6, 14, (17) (18) (19) .
Even though our data can not be generalized for JRP because of the small size of our study group, we observed that the age of onset of episodes (2.5-7 years) showed a similar pattern with the existing literature (3-6 years) (1). Leerdam et al. have carried out the most comprehensive clinical trial concerning recurrent parotitis of childhood (9) . They have encountered the median duration of episodes as 3 (2-7) days in their retrospective trial including 53 children diagnosed with JRP. They also observed diagnosis without a delay in only 30% of their series. Similarly, our patients presented with episodes lasting between 3-10 days, and only 3 out of 10 children were diagnosed in less than 6 months following the initiation of symptoms. The frequency and severity of episodes tend to subside up to puberty. Proposed mechanisms for this resolution are total atrophy or regeneration of the parotid glands over time (20) .
The diagnosis of JRP is primarily clinical. Leerdam et al. reported the most frequent clinical findings as parotid swelling, pain and fever in their series (9) . We observed similar findings in our study. Moreover, sialogram identifies multiple punctate collections indicating sialectasis. Currently, this invasive procedure has been replaced by US, which is non-invasive, easily applicable, and proven to be as sensitive as sialography (9) . Ultrasonography also rules out mass lesions, stones and abscess. Papadopoulou-Alataki et al. reported parotid swell-ing and intraparotid lymph nodes in all, and microabscesses in 30% of their study population (7) . Miziara et al. reported heterogeneous aspect, hypoechoic areas and intraparotid lymph nodes in their cases diagnosed with JRP (5). Compatible with previous research, our choice of investigation was US, which documented enlarged parotid glands with multiple hypoechoic areas. Additionally, small cystic lesions with microcalcified walls as a result of chronic inflammation may be visualized with computed tomography (CT) and magnetic resonance imaging (MRI) of the parotid gland (9, 21) . Currently, these investigations are not routinely implemented for the diagnosis of JRP for the disadvantage of irradiation risk in CT and lack of ready availability of MRI. Magnetic resonance imaging, which was undertaken for another indication, demonstrated heterogeneous parenchyma with sialoectatic foci in both parotid glands in one of our patients.
All of our patients were diagnosed with mumps following their first episodes. This finding is striking because of the existence of mumps vaccine in our routine vaccination schedule, keeping in mind the high protection feature of this vaccine. Acute infectious markers were negative for all cases. Guisa et al. and Bazsis et al. recommend evaluation for rheumatologic diseases in children with JRP (6, 19) . Cimas et al. emphasized that Sjogren syndrome in children rarely show sicca symptoms at presentation while parotitis is frequently present (22) . Our patients had negative history for rheumatologic diseases. Rheumatologic markers including Sjogren antibodies were negative in our patients. Three patients with positive ANA titer are still followed up by rheumatology. Additionally, JRP has occasionally been associated with immunodeficiencies, especially selective Ig A deficiency (18, 23, 24) . Based on the published literature, we have evaluated our series for immune There has been no consensus on appropriate treatment of JRP in children. Given the fact that the condition usually carries good prognosis, many authors suggest conservative measures, mainly consisting of hydration and analgesics (9) . The administration of antibiotics remains as a matter of debate as evidence of bacterial involvement in JRP is insufficient. Furthermore, studies comparing the outcome of patients with and without antibiotic treatment don't exist. Chitre et al. and Nahlieli et al. recommended use of antibiotics for the prevention of additional parenchymal damage (2, 25) . On the other hand, Isaacs et al advocated against the use of antibiotics (10) . They proposed no benefit of antibiotics on the outcome of attacks. Leerdam et al. suggested avoidance of antibiotics unless complications, such as abscess or cellulitis occur (9) . More recently, increasing evidence indicate success of sialendoscopy in the diagnosis and treatment of JRP (12, 13) . A meta-analysis by Canzi et al. showed high success and a very low recurrence rate after sialendoscopy and lavage with saline solutions or corticosteroids (26) . We did not refer our patients to otorhinolaryngology for sialendoscopy. Although our patients generally experienced less severe episodes with shorter duration in the follow-up, two patients had frequently repeated (7 and 12) episodes.
Conclusion
Juvenile recurrent parotitis should be kept in mind in children with repeated episodes of parotitis. The diagnosis is primarily clinical. A non-invasive imaging study, such as ultrasonography, should be considered to confirm the diagnosis and rule out mass lesions. Families should be informed that this condition is usually self-limiting, and episodes resolve by puberty. Current management is conservative. Evaluation for underlying rheumatologic diseases or immune defects is recommended.
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